ORTHO-NOVUM 7/7/7-21 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ortho-novum 7/7/7-21, and when can generic versions of Ortho-novum 7/7/7-21 launch?
Ortho-novum 7/7/7-21 is a drug marketed by Janssen Pharms and is included in one NDA.
The generic ingredient in ORTHO-NOVUM 7/7/7-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for ORTHO-NOVUM 7/7/7-21
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 7 |
Patent Applications: | 166 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ORTHO-NOVUM 7/7/7-21 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ORTHO-NOVUM 7/7/7-21
US Patents and Regulatory Information for ORTHO-NOVUM 7/7/7-21
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ORTHO-NOVUM 7/7/7-21
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Janssen Pharms | ORTHO-NOVUM 7/7/7-21 | ethinyl estradiol; norethindrone | TABLET;ORAL-21 | 018985-001 | Apr 4, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ORTHO-NOVUM 7/7/7-21
See the table below for patents covering ORTHO-NOVUM 7/7/7-21 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 1226221 | ANTI-PROGRESTATIF TRIPHASE POUR ADMINISTRATION PAR VOIE ORALE (TRIPHASIC ORAL CONTRACEPTIVE) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ORTHO-NOVUM 7/7/7-21
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0771217 | CA 2006 00038 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804 |
1214076 | C01214076/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008 |
0398460 | C300221 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DROSPIRENON EN ETHINYLESTRADIOL; REGISTRATION NO/DATE: RVG 23827 20000307 |
1453521 | 122015000093 | Germany | ⤷ Try a Trial | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
1453521 | CA 2016 00016 | Denmark | ⤷ Try a Trial | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
0771217 | 07C0001 | France | ⤷ Try a Trial | PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804 |
1380301 | CA 2009 00017 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |